Nektar Therapeutics (NKTR) Short Interest Ratio & Short Volume → 🚀 Tap into this explosive trade opportunity asap (From Daily Strike Alliance) (Ad) Free NKTR Stock Alerts $1.50 -0.14 (-8.54%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Nektar Therapeutics Short Interest DataCurrent Short Interest2,650,000 sharesPrevious Short Interest3,540,000 sharesChange Vs. Previous Month-25.14%Dollar Volume Sold Short$4.85 millionShort Interest Ratio1.0 Days to CoverLast Record DateMay 15, 2024Outstanding Shares183,620,000 sharesFloat Size178,310,000 sharesShort Percent of Float1.49%Today's Trading Volume2,736,867 sharesAverage Trading Volume2,028,617 sharesToday's Volume Vs. Average135% Short Selling Nektar Therapeutics ? Sign up to receive the latest short interest report for Nektar Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNKTR Short Interest Over TimeNKTR Days to Cover Over TimeNKTR Percentage of Float Shorted Over Time Ad Chaikin AnalyticsLog Into Marc's $5,000 System TodayNew Panic Could Sweep America Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024. More here. Nektar Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20242,650,000 shares $4.85 million -25.1%1.5%1 $1.83 4/30/20243,540,000 shares $5.17 million +13.8%2.0%1.4 $1.46 4/15/20243,110,000 shares $4.88 million +31.8%1.8%1.3 $1.57 3/31/20242,360,000 shares $2.20 million -6.0%1.3%1.2 $0.93 3/15/20242,510,000 shares $2.16 million +24.9%1.4%1.6 $0.86 2/29/20242,010,000 shares $1.43 million -18.0%1.1%1.2 $0.71 Get the Latest News and Ratings for NKTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nektar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20242,450,000 shares $1.81 million -57.8%N/A2 $0.74 1/31/20245,800,000 shares $3.15 million +6.6%N/A4.8 $0.54 1/15/20245,440,000 shares $2.91 million +1.7%N/A3.7 $0.53 12/31/20235,350,000 shares $3.02 million -23.1%N/A3.4 $0.57 12/15/20236,960,000 shares $3.26 million -3.7%N/A4.5 $0.47 11/30/20237,230,000 shares $3.54 million -9.7%N/A4.6 $0.49 11/15/20238,010,000 shares $4.21 million +7.2%N/A4.7 $0.53 10/31/20237,470,000 shares $3.50 million -8.8%N/A2.8 $0.47 10/15/20238,190,000 shares $4.41 million +5.8%N/A1.4 $0.54 9/30/20237,740,000 shares $4.61 million +6.6%N/A1.3 $0.60 9/15/20237,260,000 shares $5.12 million +7.1%N/A1.2 $0.71 8/31/20236,780,000 shares $4.03 million -5.2%N/A1 $0.60 8/15/20237,150,000 shares $5.79 million +23.3%N/A1 $0.81 7/31/20235,800,000 shares $3.11 million +9.9%N/A0.9 $0.54 7/15/20235,280,000 shares $2.90 million -2.8%N/A1.5 $0.55 6/30/20235,430,000 shares $3.12 million -50.8%N/A1.4 $0.58 6/15/202311,030,000 shares $6.23 million +11.5%N/A2 $0.56 5/31/20239,890,000 shares $5.74 million -2.1%N/A2 $0.58 5/15/202310,100,000 shares $7.71 million +5.4%N/A2 $0.76 4/30/20239,580,000 shares $7.21 million +16.7%5.8%2 $0.75 4/15/20238,210,000 shares $7.60 million -3.5%N/A1.7 $0.93 3/31/20238,510,000 shares $5.98 million +20.2%N/A1.9 $0.70 3/15/20237,080,000 shares $8.07 million -19.1%N/A2.9 $1.14 2/28/20238,750,000 shares $12.08 million -11.8%N/A4.5 $1.38 2/15/20239,920,000 shares $30.85 million -0.1%N/A4.9 $3.11 1/31/20239,930,000 shares $27.01 million +7.7%N/A6.1 $2.72 1/15/20239,220,000 shares $23.23 million +2.4%N/A5.9 $2.52 12/30/20229,000,000 shares $20.34 million -1.6%N/A5.6 $2.26 12/15/20229,150,000 shares $24.71 million -44.4%N/A5.3 $2.70 11/30/202216,470,000 shares $46.12 million -1.9%N/A9 $2.80 11/15/202216,790,000 shares $65.82 million -3.2%N/A10.6 $3.92 10/31/202217,350,000 shares $65.24 million -0.2%N/A10.6 $3.76 10/15/202217,390,000 shares $61.73 million -0.6%N/A9.5 $3.55 9/30/202217,500,000 shares $56 million -0.5%N/A7.7 $3.20Biggest Prediction of My 50-Year Career on Wall Street (Ad)"Bank Runs Will Get Worse," Expert Warns Man who predicted 2023 bank run has warned 8.4 million Americans to get out of U.S. banks immediately. Move your money into a new vehicle 50 years in the making.Click here to learn more. 9/15/202217,590,000 shares $64.38 million -0.2%N/A6.5 $3.66 8/31/202217,630,000 shares $69.46 million -6.5%N/A6.1 $3.94 8/15/202218,860,000 shares $92.60 million -0.7%N/A6.1 $4.91 7/31/202219,000,000 shares $75.24 million -19.4%N/A5.7 $3.96 7/15/202223,560,000 shares $84.34 million +17.1%N/A6.6 $3.58 6/30/202220,120,000 shares $76.46 million +14.1%N/A5.2 $3.80 6/15/202217,640,000 shares $59.27 million -1.2%N/A4.4 $3.36 5/31/202217,860,000 shares $62.15 million -1.3%N/A4.2 $3.48 5/15/202218,100,000 shares $72.22 million -1.3%N/A4.4 $3.99 4/30/202218,330,000 shares $75.70 million -10.3%N/A4.7 $4.13 4/15/202220,430,000 shares $125.85 million -2.3%N/A5.6 $6.16 3/31/202220,920,000 shares $112.76 million -12.1%N/A7 $5.39 3/15/202223,790,000 shares $106.58 million +11.5%N/A8.6 $4.48 2/28/202221,330,000 shares $218.42 million +3.6%N/A8.3 $10.24 2/15/202220,580,000 shares $230.08 million +4.7%11.4%8.2 $11.18 1/31/202219,660,000 shares $218.62 million +6.3%10.8%7.8 $11.12 1/15/202218,500,000 shares $223.85 million -2.5%10.2%7.6 $12.10 12/31/202118,980,000 shares $256.42 million +11.3%10.4%8.7 $13.51 12/15/202117,060,000 shares $221.10 million +5.7%9.4%8.4 $12.96 11/30/202116,140,000 shares $181.74 million -4.0%8.9%12.1 $11.26 11/15/202116,820,000 shares $224.38 million +3.2%9.2%14.9 $13.34 10/29/202116,300,000 shares $247.11 million +1.6%9.0%15.8 $15.16 10/15/202116,040,000 shares $277.65 million -0.9%8.8%18.7 $17.31 9/30/202116,190,000 shares $290.77 million -1.8%8.9%18.9 $17.96 9/15/202116,480,000 shares $266.65 million -5.0%9.1%19 $16.18 8/31/202117,350,000 shares $268.58 million -1.5%9.6%20.4 $15.48 8/13/202117,620,000 shares $251.79 million -2.0%9.7%20.9 $14.29 7/30/202117,970,000 shares $283.75 million +0.7%10.0%21 $15.79 7/15/202117,840,000 shares $295.97 million -1.8%9.9%19.8 $16.59 6/30/202118,160,000 shares $311.63 million -0.8%10.1%20 $17.16 6/15/202118,310,000 shares $325.00 million +1.5%10.2%20.8 $17.75 5/28/202118,040,000 shares $325.98 million -0.4%10.0%20.7 $18.07 5/14/202118,110,000 shares $341.55 million -5.9%N/A19.9 $18.86 4/30/202119,240,000 shares $386.53 million -2.2%N/A18.2 $20.09 4/15/202119,680,000 shares $376.68 million +2.1%N/A16 $19.14 3/31/202119,280,000 shares $376.15 million -3.3%N/A15.3 $19.51 3/15/202119,940,000 shares $455.03 million -6.2%N/A14.9 $22.82 2/26/202121,250,000 shares $476.85 million +0.4%N/A15.9 $22.44 2/12/202121,160,000 shares $481.39 million -7.6%N/A16.7 $22.75 1/29/202122,900,000 shares $422.28 million -4.5%N/A19.4 $18.44 1/15/202123,970,000 shares $426.67 million -1.0%N/A22.6 $17.80 12/31/202024,200,000 shares $434.15 million -1.5%N/A24 $17.94 12/15/202024,560,000 shares $433.24 million -0.3%N/A23.8 $17.64 11/30/202024,640,000 shares $413.71 million -0.2%N/A23.7 $16.79 11/15/202024,700,000 shares $426.57 million -2.1%N/A22.9 $17.27 10/30/202025,240,000 shares $409.14 million -2.5%N/A23.8 $16.21 10/15/202025,890,000 shares $454.11 million +1.7%N/A26.4 $17.54 9/30/202025,470,000 shares $422.55 million -1.3%N/A27.5 $16.59 9/15/202025,800,000 shares $516.26 million -1.7%N/A28.3 $20.01 8/31/202026,240,000 shares $507.48 million -0.7%N/A29 $19.34Biggest Prediction of My 50-Year Career on Wall Street (Ad)"Bank Runs Will Get Worse," Expert Warns Man who predicted 2023 bank run has warned 8.4 million Americans to get out of U.S. banks immediately. Move your money into a new vehicle 50 years in the making.Click here to learn more. 8/14/202026,420,000 shares $516.51 million -1.3%N/A27.5 $19.55 7/31/202026,770,000 shares $593.22 million +0.1%N/A26 $22.16 7/15/202026,740,000 shares $630.80 million -2.3%N/A24.5 $23.59 6/30/202027,360,000 shares $613.41 million -1.2%N/A23 $22.42 6/15/202027,700,000 shares $567.57 million +3.3%N/A22.3 $20.49 5/29/202026,810,000 shares $595.45 million -3.3%N/A19.4 $22.21 5/15/202027,730,000 shares $610.61 million -1.3%N/A19 $22.02 4/30/202028,090,000 shares $539.33 million -0.9%N/A18.6 $19.20 4/15/202028,340,000 shares $521.46 million +2.5%N/A18.1 $18.40 3/31/202027,640,000 shares $541.74 million +0.8%N/A13 $19.60 3/13/202027,428,900 shares $515.11 million +1.3%N/A17.3 $18.78 2/28/202027,070,000 shares $435.01 million -2.3%N/A12.4 $16.07 2/14/202027,700,000 shares $498.05 million -3.5%16.0%11.7 $17.98 1/31/202028,690,000 shares $614.25 million -3.0%16.6%10.7 $21.41 1/15/202029,590,000 shares $662.82 million +0.7%17.1%10.7 $22.40 12/31/201929,390,000 shares $621.01 million -4.9%17.0%10.9 $21.13 NKTR Short Interest - Frequently Asked Questions What is Nektar Therapeutics' current short interest? Short interest is the volume of Nektar Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 2,650,000 shares of NKTR short. 1.49% of Nektar Therapeutics' shares are currently sold short. Learn More on Nektar Therapeutics' current short interest. What is a good short interest ratio for Nektar Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NKTR shares currently have a short interest ratio of 1.0. Learn More on Nektar Therapeutics's short interest ratio. What is a good short interest percentage for Nektar Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.49% of Nektar Therapeutics' floating shares are currently sold short. Is Nektar Therapeutics' short interest increasing or decreasing? Nektar Therapeutics saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 2,650,000 shares, a decline of 25.1% from the previous total of 3,540,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Nektar Therapeutics' float size? Nektar Therapeutics currently has issued a total of 183,620,000 shares. Some of Nektar Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Nektar Therapeutics currently has a public float of 178,310,000 shares. How does Nektar Therapeutics' short interest compare to its competitors? 1.49% of Nektar Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Nektar Therapeutics: Omeros Co. (24.44%), Mersana Therapeutics, Inc. (7.35%), Nkarta, Inc. (16.27%), Revance Therapeutics, Inc. (11.96%), AC Immune SA (2.79%), UroGen Pharma Ltd. (19.06%), ADC Therapeutics SA (1.36%), Ventyx Biosciences, Inc. (16.38%), Nanobiotix S.A. (0.12%), Neoleukin Therapeutics, Inc. (0.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Nektar Therapeutics stock? Short selling NKTR is an investing strategy that aims to generate trading profit from Nektar Therapeutics as its price is falling. NKTR shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nektar Therapeutics? A short squeeze for Nektar Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NKTR, which in turn drives the price of the stock up even further. How often is Nektar Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NKTR, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: OMER Short Interest MRSN Short Interest NKTX Short Interest RVNC Short Interest ACIU Short Interest URGN Short Interest ADCT Short Interest VTYX Short Interest NBTX Short Interest NLTX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NKTR) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersDigitizing the $11T commodities sector with one tiny stockResource Stock DigestNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nektar Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.